← FDA DRUG APPROVALS

FDA ANDA · ANDA040458

CARBZAH

carbinoxamine maleate

Sponsor: GENUS

APPLICATION
ANDA040458
TYPE
ANDA
ORIGINAL APPROVAL
2003-04-25
LATEST ACTION
2010-08-25
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

CARBINOXAMINE MALEATEPrescription
CARBINOXAMINE MALEATE 4MG/5ML · SOLUTION · ORAL

Approval history

2010-08-25Labeling · Supplement 7AP
2007-08-09Labeling · Supplement 6AP
2006-06-07Labeling · Supplement 5AP
2004-04-15Labeling · Supplement 2AP
2003-04-25OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →